To date, deep neural networks have been utilized to extract dMRI metrics like ADC and FA value, and to assist IDH, MGMT, and other molecule subtype classification and prognosis prediction of glioma patients (Aliotta et al., 2019; Z. Huang et al., 2021; Yan et al., 2021). Here, MGMT is linked to glioma.